1. Home
  2. JF vs EDSA Comparison

JF vs EDSA Comparison

Compare JF & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J and Friends Holdings Limited American Depositary Shares

JF

J and Friends Holdings Limited American Depositary Shares

N/A

Current Price

$0.93

Market Cap

14.3M

Sector

N/A

ML Signal

N/A

Logo Edesa Biotech Inc.

EDSA

Edesa Biotech Inc.

N/A

Current Price

$6.45

Market Cap

7.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
JF
EDSA
Founded
2012
2015
Country
China
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
7.5M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
JF
EDSA
Price
$0.93
$6.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$13.00
AVG Volume (30 Days)
8.4K
7.0M
Earning Date
01-01-0001
05-22-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.89
$0.72
52 Week High
$1.12
$8.74

Technical Indicators

Market Signals
Indicator
JF
EDSA
Relative Strength Index (RSI) 42.54 76.31
Support Level $0.89 $1.71
Resistance Level $1.00 N/A
Average True Range (ATR) 0.04 1.13
MACD 0.00 0.49
Stochastic Oscillator 18.20 69.86

Price Performance

Historical Comparison
JF
EDSA

About JF J and Friends Holdings Limited American Depositary Shares

J and Friends Holdings Ltd, formerly Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

Share on Social Networks: